Connection
David Camidge to Cytochrome P-450 CYP3A Inhibitors
This is a "connection" page, showing publications David Camidge has written about Cytochrome P-450 CYP3A Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.025 |
|
|
|
-
Infante JR, Camidge DR, Mileshkin LR, Chen EX, Hicks RJ, Rischin D, Fingert H, Pierce KJ, Xu H, Roberts WG, Shreeve SM, Burris HA, Siu LL. Safety, pharmacokinetic, and pharmacodynamic phase I dose-escalation trial of PF-00562271, an inhibitor of focal adhesion kinase, in advanced solid tumors. J Clin Oncol. 2012 May 01; 30(13):1527-33.
Score: 0.025